Related Experiment Video
Updated: Jul 16, 2026

05:00
Rapid Characterization of Genetic Parts with Cell-Free Systems
Published on: August 30, 2021
Fluorescence-Activated Cell Sorting Enables Rapid Screening of RNA Polymerase-Promoter Interaction in E. coli
Lilian Göldel1, Ralph Krafczyk1, Romina Rathberger1
1Wacker Chemie AG , Munich, Bavaria81379, Germany.
Biochemistry
|July 14, 2026
Summary
Researchers developed a high-throughput screening platform for rapid RNA polymerase promoter identification. This method accelerates promoter characterization, improving mRNA manufacturing workflows.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- RNA polymerases are crucial for synthesizing RNA for therapeutic mRNA transcripts.
- Current methods for characterizing RNA polymerase promoters are slow and laborious.
- RNA polymerase specificity is essential for preventing abortive transcripts and byproducts.
Purpose of the Study:
- To develop a high-throughput strategy for rapid identification and characterization of RNA polymerase promoters.
- To overcome limitations of current laborious promoter characterization techniques.
- To accelerate RNA polymerase applications in mRNA manufacturing.
Main Methods:
- A two-plasmid screening platform was established in *E. coli* for promoter identification.
- Fluorescence-activated cell sorting (FACS) was employed for analyzing and sorting cell populations.
- Sequence verification was performed after cell sorting to confirm promoter functionality.
Main Results:
- The screening platform successfully sorted cell populations based on high fluorescence, validating its functionality with T7 RNA polymerase and three promoters.
- The system was evaluated using two novel RNA polymerases and their cognate promoters.
- The proof-of-concept demonstrated efficient identification of both RNA polymerase and promoter pairs.
Conclusions:
- The developed high-throughput strategy significantly accelerates promoter identification and characterization.
- This approach supports the optimization of RNA polymerase specificity for improved mRNA manufacturing.
- The platform facilitates advancements in therapeutic mRNA production by streamlining enzyme-promoter pairing.

